Hansen; Bo

Patent Applications and Registrations

Patent applications and USPTO patent grants for Hansen; Bo.The latest application filed is for "ultrasound imaging probe".

Company Profile

0.4.13

Hansen; Bo - Copenhagen DK
Hansen; Bo - Vanlose DK
Hansen; Bo - Hellerup DK
Hansen; Bo - Copenhagen K DK
Hansen; Bo - Vaerlose DK

*profile and listings may contain filings by different individuals or companies with the same name. Review application materials to confirm ownership/assignment.

Patent Activity

Patent	Date
Three dimensional (3D) vector flow imaging with BiPlane phased array transducer Grant 10,792,013 - Jensen , et al. October 6, 2	2020-10-06
Ultrasound imaging probe Grant 9,897,694 - Hansen February 20, 2	2018-02-20
Ultrasound Imaging Probe App 20170065250 - SASADY; Niels-Christian ; et al.	2017-03-09
Three Dimensional (3D) Vector Flow Imaging with BiPlane Phased Array Transducer App 20160106391 - JENSEN; Henrik ; et al.	2016-04-21
Ultrasound Imaging Probe App 20140133269 - Hansen; Bo	2014-05-15
Oligomeric Compounds For The Modulation Of Survivin Expression App 20120088907 - Hansen; Bo ; et al.	2012-04-12
Oligomeric Compounds For The Modulation Of Survivin Expression App 20100292311 - Hansen; Bo ; et al.	2010-11-18
Oligomeric compounds for the modulation of survivin expression Grant 7,713,738 - Hansen , et al. May 11, 2	2010-05-11
Rna Antagonist Compounds For The Inhibition Of Apo-b100 Expression App 20090118213 - Hansen; Henrik Frydenlund ; et al.	2009-05-07
Method and apparatus for two-step sterilization App 20080240978 - Sorensen; Jan ; et al.	2008-10-02
Oligomeric compounds for the modulation ras expression App 20080188432 - Hansen; Bo ; et al.	2008-08-07
Oligomeric compounds for the modulation survivin expression App 20050014712 - Hansen, Bo ; et al.	2005-01-20
Oligomeric compounds for the modulation of ras expression App 20040248840 - Hansen, Bo ; et al.	2004-12-09
Oligomeric compounds for the modulation of thioredoxin expression App 20040241717 - Hansen, Bo ; et al.	2004-12-02
Therapeutic uses of LNA-modified oligonucleotides in infectious diseases App 20030125241 - Wissenbach, Margit ; et al.	2003-07-03

uspto.report is an independent third-party trademark research tool that is not affiliated, endorsed, or sponsored by the United States Patent and Trademark Office (USPTO) or any other governmental organization. The information provided by uspto.report is based on publicly available data at the time of writing and is intended for informational purposes only.

While we strive to provide accurate and up-to-date information, we do not guarantee the accuracy, completeness, reliability, or suitability of the information displayed on this site. The use of this site is at your own risk. Any reliance you place on such information is therefore strictly at your own risk.

All official trademark data, including owner information, should be verified by visiting the official USPTO website at www.uspto.gov. This site is not intended to replace professional legal advice and should not be used as a substitute for consulting with a legal professional who is knowledgeable about trademark law.